OPDIVO conc perf 40 mg/4ml flac
7680656600019
CH-65660
L01FF01
07.16.1.
Reimbursement limitations:
OPDIVO.01
Cancer bronchique non à petites cellules (CBNPC) 20461.01
En monothérapie dans le traitement du cancer …
1 / 3
google
Details
- Product number
- 6566001
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- nivolumabum 40 mg, natrii citras dihydricus, natrii chloridum, mannitolum, acidum penteticum, polysorbatum 80, acidum hydrochloridum, natrii hydroxidum, aqua ad iniectabile q.s. ad solutionem pro 4 ml corresp. natrium 10 mg.
Articles (1)
Opdivo 40 mg/4 ml, Konzentrat zur Herstellung einer Infusionslösung
Konzentrat
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
40.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
10.0 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 533.05
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/04/2016
Authorization holder
Bristol-Myers Squibb SA
6312 Steinhausen
Authorization information
- Swissmedic authorization number
- 65660
- Drug name
- Opdivo, Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- KOINF
- ATC Code
- L01FF01
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 30/11/2015
- Authorization expiration date
- 31/12/9999
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- OPDIVO conc perf 40 mg/4ml flac
- Description (DE)
- OPDIVO Inf Konz 40 mg/4ml Durchstf
- Market launch
- 30/11/2015
- Narcotic (BTM)
- No